Clinical Pharmacist Impact Study

Beni-Suef University

Status: Completed

Conditions: Preventable Medication Harm; Medication Safety; Pharmacotherapy Optimization

Treatments: Other: Pharmacist-Led Medication Safety Program

Study type: Interventional

Funder types: Other

Identifiers

NCT07269002

F PH-BSU-HREC-0001025

Details and patient eligibility

About

This study evaluated a pharmacist-led medication-safety program in hospitalized patients. The program included routine inpatient medication review and the use of smartphone-based clinical decision-support applications to identify potential medication issues and support therapeutic decision-making. The study was conducted in both adult and pediatric inpatients as part of routine clinical care. No investigational drugs or devices were used.

Full description

This study was conducted to assess the impact of a structured pharmacist-led medication-safety program implemented across inpatient units in a multispecialty hospital. The program incorporated routine clinical pharmacist review of inpatient medication therapy and the use of smartphone-based clinical decision-support applications to assist with identifying potential medication issues and supporting therapeutic optimization.

The intervention was applied prospectively in both adult and pediatric inpatients receiving pharmacologic treatment. All activities were performed as part of routine clinical service enhancement, without the use of investigational drugs or devices. The study focused on evaluating medication-safety indicators, clinical process measures, and patient-related outcomes before and after implementation of the pharmacist-led program.

The aim of the project was to enhance medication accuracy, reduce preventable medication-related problems, and support evidence-based decision-making in a real-world hospital environment. This description summarizes the overall service-improvement approach without disclosing study-specific operational details.

Enrollment: 3,600 patients

Sex: All

Ages: 2+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hospitalized patients receiving medication therapy

Adult and pediatric inpatients

Patients receiving at least one scheduled medication dose during admission

Exclusion criteria

• Patients not receiving any pharmacologic treatment

Patients admitted for procedures with no medication administration

Patients discharged before assessment could be performed

Trial design

Primary purpose: Health Services Research

Allocation: Non-Randomized

Interventional model: Sequential Assignment

Masking: None (Open label)

---

3,600 participants in 2 patient groups

Control

No Intervention group

Description:

Usual inpatient medication practices before implementation of the pharmacist-led safety program.

Intervention

Other group

Description:

Structured pharmacist-led medication review and safety support using smartphone clinical decision-support applications.

Treatment:

Other: Pharmacist-Led Medication Safety Program